JBJosé Antonio Balsa

José Antonio Balsa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


José Antonio Balsa has a total of 173 co-authors. Here are the top co-authors by number of shared publications:

  • Jose Ignacio Botella Carretero

    Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain

    23 shared publications
  • Clotilde Vázquez

    Unidad de Nutrición y Dietética, Obesidad y Metabolismo, Hospital Universitario Ramón y Cajal, Ciber de Obesidad y Nutrición (CIBEROBN), Madrid, Spain

    11 shared publications
  • Isabel Zamarrón

    Unidad de Nutrición y Dietética, Obesidad y Metabolismo, Hospital Universitario Ramón y Cajal, Ciber de Obesidad y Nutrición (CIBEROBN), Madrid, Spain

    10 shared publications
  • C Vázquez

    7 shared publications
  • F Arrieta

    6 shared publications
  • Francisco Arrieta

    Unit of Clinical Nutrition and Obesity, Department of Endocrinology and Nutrition, Madrid, Spain2Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBERobn), Madrid, Spain

    6 shared publications

Latest Publications

  • Open Access

    Natural Language Processing of Unstructured Healthcare Data for Predicting Heart Failure in Individuals with Type 2 Diabetes

    by Juan F. Navarro-González, Leopoldo Pérez de Isla, Gloria Cánovas Molina, Miguel Ángel Brito-Sanfiel, David Emilio Barajas Galindo, Luis Ángel Cuellar Olmedo, Dídac Mauricio, Santiago Tofé Povedano, José Antonio Balsa Barro, Matilde Rubio Almanza, et al.

    Background/Objectives: Type 2 diabetes mellitus (T2DM) is a multisystemic disease with overlapping metabolic, renal, and cardiovascular effects. Within the Diabetic@ project, which aims to characterize individuals with T2DM using real-world data extracted from electronic health records (EHRs), this substudy sought to develop a predictive model for two-year heart failure (HF) risk. Methods: Multicenter, retrospective study including T2DM individuals across eight Spanish hospitals (2013–2018). Data were extracted exclusively from EHRs’ unstructured free text using clinical natural language processing (cNLP) and mapped to SNOMED CT. At inclusion, individuals were categorized as having or not prevalent HF (pHF). Predictive modeling was performed in non-pHF to assess two-year risk of developing HF, termed incident HF (iHF). Logistic regression (LR), decision trees, random forest, and XGBoost were compared, selecting for accuracy and interpretability. Results: Of 588,756 individuals with T2DM, 84,197 (14.3%) had pHF. Among non-pHF, 353,371 (60%) were used for model development (90.7% training, 9.3% validation). iHF occurred in 13.6% of the training set and 11.4% of the validation set. Ischemic heart disease was present in 16.2% overall, 37.9% in pHF, and 12.6% in non-pHF. Glycosylated hemoglobin data was rarely reported (<15%). LR achieved the best performance (AUC-ROC 0.73) using 27 predictors. Reduced 12- and clinically refined 9-predictor models performed similarly, with the latter implemented in a web-based tool. Conclusions: Unstructured data from EHRs enabled development of a two-year HF risk model for individuals with T2DM, underscoring the potential of cNLP for risk stratification across the cardiovascular–renal–metabolic spectrum.


  • Open Access

    Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Coronavirus Disease 2019 Severity and Mortality

    by Patricia Díaz-Guardiola, Virginia Martín-Borge, Cristina García-Fernández, María Teresa Ramírez-Prieto, Marcela Irma Ramírez-Belmar, Gema García-Romero, Esther de la Calle, José Antonio Balsa

  • Serum Bioavailable Vitamin D Concentrations and Bone Mineral Density in Women After Obesity Surgery

    by Jose I. Botella-Carretero, Christian Lafuente, Rafael Montes-Nieto, Jose Balsa, Belen Vega-Piñero, Francisca Garcia-Moreno, Roberto Peromingo, Julio Galindo, Jose L. San-Millan, Hector Escobar-Morreale

    Introduction Low bone mass after obesity surgery may arise as a consequence of chronic malabsorption of calcium and vitamin D. However, we have not found any role of serum 25-hydroxyvitamin D or of polymorphisms in the vitamin D receptor gene in previous studies. Purpose To investigate the circulating bioavailable 25-hydroxyvitamin D in women after bariatric procedures and its association with bone mass. Patients and Methods The study consisted of 91 women on follow-up for 7 ± 2 years after bariatric surgery. We measured bone mineral density (BMD), serum parathormone (PTH), 25-hydroxyvitamin D, and vitamin D binding protein (VDBP). All patients were genotyped for two variants in the coding region of VDBP (rs4588 and rs7041). Bioavailable 25-hydroxyvitamin D was calculated in double homozygotes. Results We found a negative correlation between bioavailable 25-hydroxyvitamin D and PTH (r = −0.373, P = 0.018), but not with BMD at lumbar spine (r = −0.065, P = 0.682) or hip (r = −0.029, P = 0.857). When adjusting by age, similar results were found for PTH (r = −0.441, P = 0.005), BMD at lumbar spine (r = −0.026, P = 0.874) and hip (r = −0.096, P = 0.561). After multivariate linear regression, forcing bioavailable 25-hydroxyvitamin D into the model resulted in a weak significant association with BMD at the lumbar spine (β = − 0.247, P = 0.025). Conclusions Serum bioavailable 25-hydroxyvitamin D concentrations are not associated with bone mass loss after bariatric surgery in women. The negative association with serum PTH levels suggests that vitamin D supplementation partly improves secondary hyperparathyroidism, yet other mechanisms may contribute to low bone mass after bariatric surgery.


  • Phase IV Prospective Clinical Study to Evaluate the Effect of Taurine on Liver Function in Postsurgical Adult Patients Requiring Parenteral Nutrition

    by Francisco Arrieta, José Antonio Balsa, Cristina de la Puerta, José Ignacio Botella, Isabel Zamarrón, Elena Elías, José Ignacio Pérez del Río, Paloma Alonso, Ángel Candela, Luis Miguel Blanco‐Colio, et al.

    Background: Taurine's role in bile acid metabolism and anti‐inflammatory activity could exert a protective effect on hepatobiliary complications associated with parenteral nutrition (PN). In this study, the effects of 2 amino acid solutions, with and without taurine, on liver function administered to nonacutely ill postsurgical patients as part of a short‐term PN regimen were prospectively compared. Methods: Adult patients randomly received (double‐blind) Tauramin 10% or a standard PN solution without taurine as the control (1.5 g amino acid/kg body weight [bw]/d; infusion rate of ≤4 mg glucose/kg bw/d) for a period of 5–30 days. γ‐Glutamyl transpeptidase (GGT) and other indicators of liver function, glucose metabolism, lipid profile, inflammation markers, and treatment safety data were collected. Results: Thirty‐five patients receiving taurine PN and 39 receiving control PN were enrolled (intention‐to‐treat [ITT] population). Most patients (n = 62) discontinued after day 7 of follow‐up (per‐protocol [PP] population: n = 24 and n = 27, respectively). ITT patients with high GGT values after 5 days of PN comprised 68.6% and 64.1%, respectively. The mean change in GGT values with respect to the baseline values was 167 ± 192 and 157 ± 185 IU/L, respectively. Low‐density lipoprotein (LDL) cholesterol levels after 7 days of PN were significantly decreased in the taurine PN group of PP patients (–2.83 ± 30.9 vs 23.9 ± 27.0 mg/dL for control PN; P < .05). None of the adverse events reported (taurine PN: n = 6; control PN: n = 7) were treatment related. Conclusion: PN solutions with and without taurine had similar effects on liver function parameters, except for an LDL reduction in PN with taurine, when administered to nonacutely ill postsurgical patients in the short term (5–7 days).


  • Estimación del impacto económico y sanitario de las complicaciones de la diabetes mellitus tipo 2 en la Comunidad de Madrid

    by Francisco Arrieta, Carlos Rubio-Terrés, Darío Rubio-Rodríguez, Ana Magaña, Marbella Piñera, Pedro Iglesias, Pedro Nogales, Alfonso Calañas, Blanca Novella, José Ignacio Botella-Carretero, et al.


  • Metabolic control and chronic complications during a 3-year follow-up period in a cohort of type 2 diabetic patients attended in primary care in the Community of Madrid (Spain)

    by Francisco Arrieta, Marbella Piñera, Pedro Iglesias, Pedro Nogales, Miguel Angel Salinero-Fort, Juan Carlos Abanades, José Ignacio Botella-Carretero, Alfonso Calañas, José Antonio Balsa, Isabel Zamarrón, et al.


  • Carga de la enfermedad atribuible al hipotiroidismo subclínico en la población española

    by S. Donnay, J.A. Balsa, J. Álvarez, C. Crespo, F. Pérez-Alcántara, C. Polanco


  • Role of Peripherally Inserted Central Catheters in Home Parenteral Nutrition

    by Jose I. Botella‐Carretero, Carmen Carrero, Eva Guerra, Beatriz Valbuena, Francisco Arrieta, Alfonso Calañas, Isabel Zamarrón, Jose A. Balsa, Clotilde Vázquez

    Background: Home parenteral nutrition (HPN) has become a common therapy, with tunneled central venous catheters (CVCs) being preferred for its administration. Peripherally inserted central catheters (PICCs) are not currently recommended for long‐term HPN, although evidence to support this statement is scarce. The authors aimed to evaluate the outcomes of HPN, focusing on CVC‐related complications. Materials and Methods: All patients attended at the authors’ center for HPN from 2007–2011 were prospectively included. HPN composition aimed at 20–35 kcal/kg/d, 3–6 g/kg/d of glucose, 1.0 g/kg/d of amino acids, and Results: Seventy‐two patients received HPN, with 79 implanted CVCs (48 PICCs, 10 Hickman, and 21 ports). Mean catheter‐days were 129.1 for PICCs, 98.5 for Hickman, and 67.7 for ports (P = .685). When analyzing CRBSIs, ports had 44, Hickman had 20, and PICC had 0 episodes per 1000 catheter‐days (P = .078). Only PICCs showed less incidence of CRBSIs vs ports (P = .043). Multivariate logistic regression, correcting by catheter‐days, patients’ age and sex, underlying disease, and type of catheter, showed that only catheter‐days (P = .031) was a predictor for CRBSIs (P = .007, Nagelkerke R= = 0.246). Conclusion: PICCs are similar in terms of catheter‐related complications to other CVCs for the administration of HPN, especially for oncology patients with HPN lasting <6 months.


  • Circulating free testosterone in obese men after bariatric surgery increases in parallel with insulin sensitivity

    by J I Botella-Carretero, J A Balsa, J M Gómez-Martin, R Peromingo, L Huerta, M Carrasco, F Arrieta, I Zamarron, A Martin-Hidalgo, C Vazquez

    Male hypogonadism has been linked to obesity and diabetes. We aimed to study the association of changes in insulin sensitivity and testosterone levels in severe obese patients submitted to bariatric surgery. Prospective intervention study with twenty consecutive patients who underwent bariatric surgery studied before and after significant weight loss. Serum testosterone, SHBG, fasting glucose, and insulin were measured among others. Free testosterone was calculated with the Vermeulen formula and insulin sensitivity with the homeostatic model assessment (HOMA). At baseline, thirteen patients had low total testosterone levels, whereas eight of these patients also had free testosterone levels below the reference range obtained from the control group. After bariatric surgery total testosterone, SHBG, and free testosterone significantly increased and achieved normal values in all evaluated patients. Insulin sensitivity improved in all of them. Multivariate linear regression showed that changes in fasting glucose (β=-1.868, p=0.001), insulin (β=-3.782, p=0.001), weight (β=-0.622, p=0.002), and SHBG (β=-0.635, p=0.022) were associated with changes in free testosterone (adjusted R2=0.936, F=26.613, p=0.001). When insulin resistance calculated by HOMA was in the model instead of insulin and glucose, it also was associated (β=-3.488, p=0.008) with free testosterone (adjusted R2=0.821, F=11.111, p=0.005). Circulating tes tos terone in obese men increases after bariatric surgery in parallel with an improvement in insulin sensitivity.


  • Chylous ascytes secondary to acute pancreatitis: a case report and review of literature.

    by J M Gómez-Martín, E Martínez-Molina, A Sanjuanbenito, E Martín-Illana, F Arrieta, J A Balsa, I Zamarrón, C Vázquez, J I Botella-Carretero

    Chylous ascites is an uncommon finding which is due to the presence of thoracic or intestinal lymph in the abdominal cavity. It is usually caused by a chronic disruption of the lymphatic system. The present report is one of the rare cases in the literature of chylous ascites secondary to idiopathic acute pancreatitis, which showed a complete resolution with a combination of low fat enteral nutrition with MCT and somatostatin analogs.